These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1675379)

  • 1. Case-control study of screening for prostatic cancer by digital rectal examinations.
    Friedman GD; Hiatt RA; Quesenberry CP; Selby JV
    Lancet; 1991 Jun; 337(8756):1526-9. PubMed ID: 1675379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study.
    Weinmann S; Richert-Boe KE; Van Den Eeden SK; Enger SM; Rybicki BA; Shapiro JA; Weiss NS
    Epidemiology; 2005 May; 16(3):367-76. PubMed ID: 15824554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening digital rectal examination and prostate cancer mortality: a case-control study.
    Richert-Boe KE; Humphrey LL; Glass AG; Weiss NS
    J Med Screen; 1998; 5(2):99-103. PubMed ID: 9718529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is deleting the digital rectal examination a good idea?
    Sutton MA; Gibbons RP; Correa RJ
    West J Med; 1991 Jul; 155(1):43-6. PubMed ID: 1877229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of serial digital rectal examinations in screening for prostate cancer.
    Mueller EJ; Crain TW; Thompson IM; Rodriguez FR
    J Urol; 1988 Dec; 140(6):1445-7. PubMed ID: 3193513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated screening for carcinoma of the prostate by digital rectal examination in a randomly selected population.
    Varenhorst E; Carlsson P; Capik E; Löfman O; Pedersen KV
    Acta Oncol; 1992; 31(8):815-21. PubMed ID: 1290631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam.
    van der Cruijsen-Koeter IW; van der Kwast TH; Schröder FH
    J Natl Cancer Inst; 2003 Oct; 95(19):1462-6. PubMed ID: 14519752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 11. Early detection of prostate cancer by routine screening.
    Chodak GW; Schoenberg HW
    JAMA; 1984 Dec; 252(23):3261-4. PubMed ID: 6512929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital rectal examination to screen for prostatic cancer.
    Waaler G; Ludvigsen TC; Runden TO; Stenehjem E; Ogreid P; Schei OM
    Eur Urol; 1988; 15(1-2):34-6. PubMed ID: 3215234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
    Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
    Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum.
    Herrinton LJ; Selby JV; Friedman GD; Quesenberry CP; Weiss NS
    Am J Epidemiol; 1995 Nov; 142(9):961-4. PubMed ID: 7572977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-specific survival following routine prostate cancer screening by digital rectal examination.
    Gerber GS; Thompson IM; Thisted R; Chodak GW
    JAMA; 1993 Jan; 269(1):61-4. PubMed ID: 8416407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the prostate. Do yearly digital rectal examinations save lives?
    Mueller EJ
    Postgrad Med; 1989 Nov; 86(7):115-9. PubMed ID: 2813222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is a screening test? Misclassification bias in observational studies of screening for cancer.
    Concato J
    J Gen Intern Med; 1997 Oct; 12(10):607-12. PubMed ID: 9346456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of determining prostate-specific antigen for early detection or prostatic carcinoma].
    Hammerer P; Huland H
    Urologe A; 1995 Jul; 34(4):283-9. PubMed ID: 7545842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of rectal exploration, suprapubic and transrectal prostatic ultrasonography, and PSA in the diagnosis and follow-up of prostatic carcinoma].
    Speranza I; Bianco V; Banci M; Muià R; Gianni W; Bacciu O; Vecchione A; Marchei P
    Minerva Med; 1998; 89(7-8):267-75. PubMed ID: 9824988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
    Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
    J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.